PhotonEra Secures $210M in Series C Funding for Chinese Computing Power

Select Language:

PhotonEra announced that it has secured over 1.5 billion CNY (approximately $210 million USD) in a Series C funding round, aimed at strengthening its position as a leader in the global market for hybrid photonic-electronic computing solutions in China.

Participating in the funding were new investors such as China Mobile, Shanghai State-Owned Capital Investment, China Reform Holdings Corporation Fund, and Shanghai Pudong Venture Capital. Existing investors, including CAS Star, Yijing Capital, and a major internet company, also contributed to the round, the company revealed.

“The large-scale integration of photonic technology has reached a vital stage of commercialization,” stated Shen Yichen, the founder and CEO. Shen also noted that within the next five years, photonic chips could account for up to 30% of smart data centers’ computing infrastructure.

This new investment will fast-track the development of core technology and facilitate the large-scale deployment of hybrid photonic-electronic computing systems, Shen added.

The company has developed critical expertise in optical and electrical chip technologies, along with system integration capabilities. With a forward-thinking approach and strong engineering skills, PhotonEra aims to convert advanced tech innovations into widespread commercial applications. China Mobile highlighted that the company is set to become a key contributor to next-generation computing enhancements, especially as photonic-electronic integration becomes increasingly essential in computing infrastructure.

Founded in 2017 and based in Shanghai, PhotonEra specializes in providing efficient computing solutions driven by large-scale photonic integration technology, especially relevant in today’s era of AI and big data. Its offerings include photonic computing and networking services designed to support clients across industries such as big data analytics, cloud computing, finance, autonomous vehicles, biomedical research, and materials science.